Clinical Trials on Secondary Progress Multiple Sclerosis
Total 3181 results
-
Bayhill TherapeuticsCompletedRelapsing Remitting Multiple Sclerosis
-
University of MalagaUnknownRelapsing-remitting Multiple SclerosisSpain
-
Icahn School of Medicine at Mount SinaiWithdrawnRelapsing-remitting Multiple Sclerosis (RRMS)United States
-
Institut National de la Santé Et de la Recherche...BiogenUnknownNervous System Diseases | Progressive Multiple Sclerosis | Multiple Sclerosis | Eye Diseases | Optic Neuritis | Optic Nerve Diseases | Relapsing Remitting Multiple SclerosisFrance
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing Multiple Sclerosis | Advancing Multiple SclerosisUnited States, Puerto Rico
-
Dent Neuroscience Research CenterGenentech, Inc., a subsidiary of F. Hoffman-La Roche AG; Monogram Biosciences...Not yet recruitingMultiple Sclerosis | Relapsing Remitting Multiple Sclerosis
-
NHS Greater Glasgow and ClydeBiogenEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Eisai Korea Inc.CompletedMultiple Sclerosis, Relapsing-remittingKorea, Republic of
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
-
BiocadCompleted
-
University at BuffaloWithdrawn
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
Assistance Publique - Hôpitaux de ParisFondation ARSEP/AFMCompletedRelapsing Remitting Multiple SclerosisFrance
-
MSDx, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States
-
OhioHealthCompletedRelapsing Remitting Multiple SclerosisUnited States
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Patient-Centered Outcomes Research Institute; Universita degli Studi di GenovaTerminatedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsCompleted
-
Isfahan University of Medical SciencesShiraz University of Medical SciencesCompleted
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
Charite University, Berlin, GermanyBayerTerminatedRelapsing Remitting Multiple SclerosisGermany
-
BiogenCompletedRelapsing Remitting Multiple SclerosisGermany
-
GlaxoSmithKlineCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandNovartisCompletedRelapsing Remitting Multiple SclerosisSwitzerland
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
Revalesio CorporationWithdrawnRelapsing Remitting Multiple SclerosisUnited States
-
University at BuffaloCharles University, Czech Republic; General University Hospital, PragueCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
University of Wisconsin, MadisonCompletedRelapsing Remitting Multiple SclerosisUnited States
-
University Hospital MuensterNovartisUnknownRelapsing Remitting Multiple SclerosisGermany
-
Johns Hopkins UniversityBiogenWithdrawn
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing Remitting Multiple Sclerosis
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
BiogenCompleted
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedRelapsing Remitting Multiple SclerosisSerbia, Bulgaria, Poland, Russian Federation, Slovakia, Ukraine
-
University Hospital Inselspital, BernePharmaPart; Laboratory: Viollier AG Spalenring 145 / 147 Postfach 4002 BaselCompletedMultiple SclerosisSwitzerland
-
Washington Neuropsychology Research GroupGenzyme, a Sanofi CompanyUnknownRelapsing Remitting Multiple SclerosisUnited States
-
Alabama Neurology Associates, PCBiogenUnknownRelapsing Remitting Multiple SclerosisUnited States
-
Multiple Sclerosis InstituteUnknown
-
Johns Hopkins UniversityCompletedProgressive Multiple SclerosisUnited States
-
SanofiCompletedProgressive Multiple SclerosisGermany
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedPrimary Progressive Multiple SclerosisUnited States, Canada, Germany, Italy, Netherlands, Poland, Russian Federation, Spain, Ukraine, United Kingdom
-
Indiana UniversityUniversity of Alabama at Birmingham; University of OttawaCompletedProgressive Multiple SclerosisUnited States
-
Nantes University HospitalCompletedProgressive Multiple SclerosisFrance
-
University of CalgaryCompletedMultiple Sclerosis, Primary ProgressiveCanada
-
National Institute of Allergy and Infectious Diseases...CompletedMultiple Sclerosis | Primary Progressive Multiple SclerosisUnited States
-
Genzyme, a Sanofi CompanyCompletedProgressive Multiple SclerosisSpain
-
Turku University HospitalCompletedMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingFinland